Our results demonstrated that this novel multi‐epigenetic modifier inhibitor efficiently inhibited SPOP‐mutated PCa cell growth in cell culture, organoid, PDX, and mouse xenograft models. The gene discussed is SPOP; the disease is posterior cortical atrophy.